It's very important to take the EMPEROR-Reduced and DAPA-HF trials together as being complimentary, said Milton Packer, MD, a distinguished scholar in cardiovascular science at Baylor University Medical Center in Dallas, and chair of the department of clinical sciences at the University of Texas Southwestern Medical School.